# A Study of Nilotinib in Growing Vestibular Schwannomas

> **NCT01201538** · PHASE2 · TERMINATED · sponsor: **University Health Network, Toronto** · enrollment: 2 (actual)

## Conditions studied

- Growing Vestibular Schwannomas

## Interventions

- **DRUG:** Nilotinib

## Key facts

- **NCT ID:** NCT01201538
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-10
- **Primary completion:** 2011-10
- **Final completion:** 2013-10
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Study PI passed away We had trouble recruiting for the drug arm
- **Last updated:** 2017-01-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01201538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01201538, "A Study of Nilotinib in Growing Vestibular Schwannomas". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01201538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*